相关实验视频
Updated: Jun 19, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.5K
使用贝叶斯核心机器回归检测药物混合物的单变体,双变体和整体效应
Jemar R Bather1,2, Larry Han3, Alex S Bennett1,4,5
1Center for Anti-Racism, Social Justice & Public Health, New York University School of Global Public Health, New York, NY, USA.
The American journal of drug and alcohol abuse
|July 23, 2024
概括
贝叶斯核机回归 (BKMR) 有效地分析药物混合物,确定芬太尼和尼塔是对不良健康结果的关键贡献者. 这种创新方法提高了对物质使用影响的理解.
科学领域:
- 流行病学 流行病学
- 生物统计学 生物统计学
- 毒理学 毒理学 毒理学
- 公共卫生 公共卫生
背景情况:
- 目前的药物研究通常集中在单一物质上,限制了对多种药物使用影响的理解.
- 创新的分析方法对于检查非法药物使用者的复杂药物混合物至关重要.
- 在环境流行病学中建立的贝叶斯核机器回归 (BKMR) 为物质使用研究提供了一种新的方法.
研究的目的:
- 为了证明贝叶斯内核机器回归 (BKMR) 方法的实用性.
- 在模拟的非法药物使用者中调查阿片类药物和非阿片类药物的联合使用对健康的影响.
- 分析药物混合物对健康结果的影响.
主要方法:
- 用Vale和Maurelli方法对200个个体进行模拟数据,用于多变量非正常药物暴露.
- 克西拉,芬太尼,二和尼塔的模拟度.
- 采用10,000个马尔科夫链蒙特卡洛 (MCMC) 采样代与诊断 (跟踪图,r-hat,有效样本大小) 来确保模型稳定性.
主要成果:
- 在对年龄进行控制后,更高的芬太尼和尼塔度显著与模拟健康结果水平的增加有关.
- BKMR模型诊断证实了多个马尔科夫链的稳定性和可靠性.
- 视觉化展示了药物混合物中的单变体,双变体和累积暴露-反应关系.
结论:
- 贝叶斯核机器回归 (BKMR) 方法为剖析药物混合物的复杂影响提供了一个强大的工具.
- BKMR可以区分混合物中的单个物质所带来的相对健康风险.
- 该方法适用于评估药物对健康结果的单变量,双变量和累积药物影响,推进物质使用研究.
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
Analysis of Population Pharmacokinetic Data
251
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
251
Drug Concentration Versus Time Correlation
709
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
709
Mechanistic Models: Compartment Models in Individual and Population Analysis
35
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
35
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
66
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
66

